Bergonzini Patrizia, Caramaschi Elisa, Spallino Alessandra, Dell'Isola Giovanni Battista, Spezia Elisabetta, Verrotti Alberto, Iughetti Lorenzo
Pediatric Unit, Department of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena 41121, Italy.
Pediatric Unit, Department of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena 41121, Italy.
Clin Neurol Neurosurg. 2025 Feb;249:108673. doi: 10.1016/j.clineuro.2024.108673. Epub 2024 Dec 4.
Typical absence seizures represent a distinctive form of epileptic activity typically observed in pediatric populations, predominantly manifesting between the ages of 4 and 10, constituting Childhood Absence Epilepsy (CAE). However, a subset of patients presents with Early-onset Absence Epilepsy (EOAE), characterized by seizure onset before the fourth year of life, often displaying favorable outcomes with antiseizure medication. Conversely, atypical absence seizures exhibit prolonged duration and frequently entail tonic, atonic, or myoclonic motor elements, suggesting a more severe clinical course, commonly associated with epileptic encephalopathies of childhood onset. Recent genetic investigations have highlighted the involvement of specific genes, notably the SLC1A2 mutation, identified in 10 % of EOAE cases, underlying the GLUT1 deficiency syndrome. Timely recognition of such genetic anomalies facilitates tailored interventions, including ketogenic dietary regimes, shown to ameliorate epileptic symptomatology and neurocognitive sequelae. This retrospective study aimed to delineate the distinct features of EOAE and early-onset atypical absence seizures, facilitating prompt diagnosis, particularly emphasizing genetic aberrations, and initiating precision therapeutic approaches to optimize patient outcomes. Evaluation of 23 patients with absence epilepsy onset within the first four years of life, conducted at the Neuropediatrics Outpatient Clinic of the Policlinico of Modena, revealed that children with atypical absences often exhibit a complex clinical and electroencephalographic phenotype, frequently associated with genetic abnormalities. Notably, neurocognitive prognosis appears less favorable in this subgroup, with half of the patients displaying pharmacoresistance. In contrast, all EOAE cases demonstrated seizure freedom, corroborating previous literature suggesting a relatively benign clinical course in these individuals.
典型失神发作是一种独特的癫痫活动形式,常见于儿童群体,主要发病年龄在4至10岁之间,构成儿童失神癫痫(CAE)。然而,一部分患者表现为早发性失神癫痫(EOAE),其特征是在4岁前发病,通常对抗癫痫药物治疗效果良好。相反,非典型失神发作持续时间较长,常伴有强直、失张力或肌阵挛性运动成分,提示临床病程较为严重,通常与儿童期起病的癫痫性脑病相关。最近的基因研究强调了特定基因的参与,特别是在10%的EOAE病例中发现的SLC1A2突变,这是葡萄糖转运蛋白1缺乏综合征的基础。及时识别此类基因异常有助于进行针对性干预,包括生酮饮食疗法,已证明该疗法可改善癫痫症状和神经认知后遗症。这项回顾性研究旨在描述EOAE和早发性非典型失神发作的独特特征,促进早期诊断,尤其强调基因畸变,并启动精准治疗方法以优化患者预后。在摩德纳综合医院神经儿科门诊对23例在生命的前四年内发病的失神癫痫患者进行评估后发现,非典型失神发作的儿童通常表现出复杂的临床和脑电图表型,常与基因异常相关。值得注意的是,该亚组患者的神经认知预后似乎较差,一半的患者表现出药物抵抗。相比之下,所有EOAE病例均实现了无癫痫发作,这证实了先前文献表明这些个体临床病程相对良性。